In our previous study, we demonstrated that interleukin 10 and free light chains in CSF can potentially serve as protein markers for diagnosis and chemotherapy efficacy monitoring in PCNSL [13, 14]. The gene discussed is IL10; the disease is primary central nervous system lymphoma.